These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 19185786

  • 1. [Rivaroxaban: mode of action].
    Drouet L.
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786
    [Abstract] [Full Text] [Related]

  • 2. [Rivaroxaban (Xarelto): efficacy and safety].
    Rosencher N, Arnaout L, Chabbouh T, Bellamy L.
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S22-7. PubMed ID: 19185784
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V, Perzborn E, Heitmeier S, von Degenfeld G, Dittrich-Wengenroth E, Buchmüller A, Gerdes C, Misselwitz F.
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [Abstract] [Full Text] [Related]

  • 6. [Summary and perspectives. Rivaroxaban].
    Albaladejo P.
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S28-31. PubMed ID: 19185785
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rivaroxaban: new drug. After hip or knee replacement surgery: LMWH is safer.
    Prescrire Int; 2009 Aug; 18(102):151-3. PubMed ID: 19743567
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rivaroxaban: a novel, oral, direct factor Xa inhibitor.
    Abrams PJ, Emerson CR.
    Pharmacotherapy; 2009 Feb; 29(2):167-81. PubMed ID: 19170587
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
    Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Muehlhofer E, Dierig C, Misselwitz F, Kälebo P, ODIXa-HIP Study Investigators.
    Circulation; 2006 Nov 28; 114(22):2374-81. PubMed ID: 17116766
    [Abstract] [Full Text] [Related]

  • 17. New antithrombotic drugs: potential for use in oncology.
    Levine MN.
    J Clin Oncol; 2009 Oct 10; 27(29):4912-8. PubMed ID: 19738103
    [Abstract] [Full Text] [Related]

  • 18. [Rivaroxaban in the prevention and treatment of thromboembolic disorders].
    Helbing T, Bode C, Moser M.
    Hamostaseologie; 2012 Oct 10; 32(3):195-202. PubMed ID: 22777255
    [Abstract] [Full Text] [Related]

  • 19. [New anticoagulants--are we prepared?].
    Pawlikowska Z, Szponar J.
    Przegl Lek; 2012 Oct 10; 69(8):483-5. PubMed ID: 23243913
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.